Page 50 - Petelin, Ana, in Helena Skočir. 2020. Ur. Raziskovanje za znanje, znanje za zdravje. Zbornik prispevkov z recenzijo. Koper: Založba Univerze na Primorskem.
P. 50
iskovanje za znanje, znanje za zdravje GULLETT, P. N., MAZURAK, V., HEBBAR, G. in ZIEGLER, R. T., 2011. Nutritional interventions
for cancer-induced cachexia. Current problems in cancer, vol. 35, (2), str. 58–90. Pridob-
ljeno 23. 2. 2020 s https://doi.org/10.1016/j.currproblcancer.2011.01.001
HAM, D. J., MURPHY, K. T., CHEE, A., LYNCH, G. S. in KOOPMAN, R., 2014. Glycine Adminis-
tration Attenuates Skeletal Muscle Wasting in a Mouse Model of Cancer Cachexia
[online]. Clinical Nutrition, vol. 33, (3), str. 448–458. Pridobljeno 23. 2. 2020 s https://doi.
org/10.1016/j.clnu.2013.06.013
JURDANA, M., 2009. Cancer cachexia-anorexia syndrome and skeletal muscle wasting
[online]. Radiology and oncology, vol. 43, (2), str. 65–75. Pridobljeno 23. 2. 2020 s https://
doi.org/10.2478/v10019-009-0007-y
KOZJEK, N. R., LAHAJNAR, S., SNOJ, Z. in SMRDEL, A. C. Š., 2009. Podporna terapija raka. V:
NOVAKOVIĆ, S., HOČEVAR, M., NOVAKOVIĆ, B. J., STROJAN, P. IN ŽGAJNAR, J., ur. On-
kologija: raziskovanje, diagnostika in zdravljenje raka. (str. 184–201). Ljubljana: Mladin-
ska knjiga.
LISSONI, P., PAOLOROSSI, F., TANCINI, G., BARNI, S., ARDIZZOIA, A., BRIVIO, F., ZUBELEWICZ,
B. in CHATIKHINE, V., 1996. Is There a Role for Melatonin in the Treatment of Neoplas-
tic Cachexia? European Journal of Cancer (Oxford, England: 1990), vol. 32A, (8), str. 1340–
1343.
MADEDDU, C., DESSÌ, M., PANZONE, F., SERPE, R., ANTONI, G., CAU, M. C., MONTALDO, L.,
MELA, Q., MURA, M., ASTARA, G. et. al., 2012. Randomized Phase III Clinical Trial of a
Combined Treatment with Carnitine + Celecoxib ± Megestrol Acetate for Patients
with Cancer-Related Anorexia/Cachexia Syndrome [online]. Clinical Nutrition, vol. 31,
(2), str. 176–182. Pridobljeno 23. 2. 2020 s https://doi.org/10.1016/j.clnu.2011.10.005
PRIETO, I., MONTEMUIÑO, S., LUNA, J., DE TORRES, M. V. in AMAYA, E., 2017. The role of
immunonutritional support in cancer treatment: Current evidence [online]. Clinical
Nutrition, vol. 36, (6), str. 1457–1464. Pridobljeno 23. 2. 2020 s https://doi.org/10.1016/j.
clnu.2016.11.015
SADEGHI, M., KESHAVARZ-FATHI, M., BARACOS, V., ARENDS, J., MAHMOUDI, M. in REZAEI,
N., 2018. Cancer Cachexia: Diagnosis, Assessment, and Treatment [online]. Critical Re-
views in Oncology / Hematology, vol. 127, str. 91–104. Pridobljeno 23. 2. 2020 s https://
doi.org/10.1016/j.critrevonc.2018.05.006
STEPHENS, N. A. in FEARON, K. C. H., 2008. Anorexia, Cachexia and Nutrition [online].
Medicine, vol. 36, (2), str. 78–81. Pridobljeno 23. 2. 2020 s https://doi.org/10.1016/j.
mpmed.2007.11.004
TEMEL, J., BONDARDE, S., JAIN, M., ALLEN, S. in MANN, W., 2013. Efficacy and safety of
anamorelin HCL in NSCLC patients: results from a randomized, double-blind, place-
bo-controlled, multicenter phase II study. Eur J Cancer, vol. 49, (2), Abstract 1308.
TSUBOUCHI, H., YANAGI, S., MIURA, A., MATSUMOTO, N., KANGAWA, K. in NAKAZATO, M.,
2014. Ghrelin relieves cancer cachexia associated with the development of lung ade-
nocarcinoma in mice [online]. European Journal of Pharmacology, vol. 743, str. 1–10. Pri-
dobljeno 23. 2. 2020 s https://doi.org/10.1016/j.ejphar.2014.09.025
TUCA, A., JIMENEZ-FONSECA, P. in GASCÓN, P., 2013. Clinical Evaluation and Optimal
Management of Cancer Cachexia [online]. Critical Reviews in Oncology / Hematolo-
gy, vol. 88, (3), str. 625–636. Pridobljeno 23. 2. 2020 s https://doi.org/10.1016/j.critre-
vonc.2013.07.015
VANHOUTTE, G., VAN DE WIEL, M., WOUTERS, K., SELS, M., BARTOLOMEEUSSEN, L., DE KE-
ERSMAECKER, S., VERSCHUEREN, C., DE VROEY, V., DE WILDE, A., SMITS, E. et. al., 2016.
Cachexia in cancer: what is in the definition [online]? BMJ open gastroenterology, vol.
3, (1), str. 1–9. Pridobljeno 23. 2. 2020 s http://dx.doi.org/10.1136/bmjgast-2016-000097
48
for cancer-induced cachexia. Current problems in cancer, vol. 35, (2), str. 58–90. Pridob-
ljeno 23. 2. 2020 s https://doi.org/10.1016/j.currproblcancer.2011.01.001
HAM, D. J., MURPHY, K. T., CHEE, A., LYNCH, G. S. in KOOPMAN, R., 2014. Glycine Adminis-
tration Attenuates Skeletal Muscle Wasting in a Mouse Model of Cancer Cachexia
[online]. Clinical Nutrition, vol. 33, (3), str. 448–458. Pridobljeno 23. 2. 2020 s https://doi.
org/10.1016/j.clnu.2013.06.013
JURDANA, M., 2009. Cancer cachexia-anorexia syndrome and skeletal muscle wasting
[online]. Radiology and oncology, vol. 43, (2), str. 65–75. Pridobljeno 23. 2. 2020 s https://
doi.org/10.2478/v10019-009-0007-y
KOZJEK, N. R., LAHAJNAR, S., SNOJ, Z. in SMRDEL, A. C. Š., 2009. Podporna terapija raka. V:
NOVAKOVIĆ, S., HOČEVAR, M., NOVAKOVIĆ, B. J., STROJAN, P. IN ŽGAJNAR, J., ur. On-
kologija: raziskovanje, diagnostika in zdravljenje raka. (str. 184–201). Ljubljana: Mladin-
ska knjiga.
LISSONI, P., PAOLOROSSI, F., TANCINI, G., BARNI, S., ARDIZZOIA, A., BRIVIO, F., ZUBELEWICZ,
B. in CHATIKHINE, V., 1996. Is There a Role for Melatonin in the Treatment of Neoplas-
tic Cachexia? European Journal of Cancer (Oxford, England: 1990), vol. 32A, (8), str. 1340–
1343.
MADEDDU, C., DESSÌ, M., PANZONE, F., SERPE, R., ANTONI, G., CAU, M. C., MONTALDO, L.,
MELA, Q., MURA, M., ASTARA, G. et. al., 2012. Randomized Phase III Clinical Trial of a
Combined Treatment with Carnitine + Celecoxib ± Megestrol Acetate for Patients
with Cancer-Related Anorexia/Cachexia Syndrome [online]. Clinical Nutrition, vol. 31,
(2), str. 176–182. Pridobljeno 23. 2. 2020 s https://doi.org/10.1016/j.clnu.2011.10.005
PRIETO, I., MONTEMUIÑO, S., LUNA, J., DE TORRES, M. V. in AMAYA, E., 2017. The role of
immunonutritional support in cancer treatment: Current evidence [online]. Clinical
Nutrition, vol. 36, (6), str. 1457–1464. Pridobljeno 23. 2. 2020 s https://doi.org/10.1016/j.
clnu.2016.11.015
SADEGHI, M., KESHAVARZ-FATHI, M., BARACOS, V., ARENDS, J., MAHMOUDI, M. in REZAEI,
N., 2018. Cancer Cachexia: Diagnosis, Assessment, and Treatment [online]. Critical Re-
views in Oncology / Hematology, vol. 127, str. 91–104. Pridobljeno 23. 2. 2020 s https://
doi.org/10.1016/j.critrevonc.2018.05.006
STEPHENS, N. A. in FEARON, K. C. H., 2008. Anorexia, Cachexia and Nutrition [online].
Medicine, vol. 36, (2), str. 78–81. Pridobljeno 23. 2. 2020 s https://doi.org/10.1016/j.
mpmed.2007.11.004
TEMEL, J., BONDARDE, S., JAIN, M., ALLEN, S. in MANN, W., 2013. Efficacy and safety of
anamorelin HCL in NSCLC patients: results from a randomized, double-blind, place-
bo-controlled, multicenter phase II study. Eur J Cancer, vol. 49, (2), Abstract 1308.
TSUBOUCHI, H., YANAGI, S., MIURA, A., MATSUMOTO, N., KANGAWA, K. in NAKAZATO, M.,
2014. Ghrelin relieves cancer cachexia associated with the development of lung ade-
nocarcinoma in mice [online]. European Journal of Pharmacology, vol. 743, str. 1–10. Pri-
dobljeno 23. 2. 2020 s https://doi.org/10.1016/j.ejphar.2014.09.025
TUCA, A., JIMENEZ-FONSECA, P. in GASCÓN, P., 2013. Clinical Evaluation and Optimal
Management of Cancer Cachexia [online]. Critical Reviews in Oncology / Hematolo-
gy, vol. 88, (3), str. 625–636. Pridobljeno 23. 2. 2020 s https://doi.org/10.1016/j.critre-
vonc.2013.07.015
VANHOUTTE, G., VAN DE WIEL, M., WOUTERS, K., SELS, M., BARTOLOMEEUSSEN, L., DE KE-
ERSMAECKER, S., VERSCHUEREN, C., DE VROEY, V., DE WILDE, A., SMITS, E. et. al., 2016.
Cachexia in cancer: what is in the definition [online]? BMJ open gastroenterology, vol.
3, (1), str. 1–9. Pridobljeno 23. 2. 2020 s http://dx.doi.org/10.1136/bmjgast-2016-000097
48
